Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 Short-Acting Bronchodilators
    • 1.1.2.2 Corticosteroids
    • 1.1.2.3 Methylxanthines
    • 1.1.2.4 Long-Acting Bronchodilators
    • 1.1.2.5 Phosphodiesterase-4 Inhibitors
  • 1.1.3 Market by Application
    • 1.1.3.1 GOLD 1? FEV1 ? 80%
    • 1.1.3.2 GOLD 2? 50% ? FEV1 < 80%
    • 1.1.3.3 GOLD 3? 30% ? FEV1 < 50%
    • 1.1.3.4 GOLD 4? FEV1 < 30%
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 AstraZeneca
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 Boehringer Ingelheim
• 6.3 GSK
• 6.4 Novartis
• 6.5 Teva Pharmaceuticals
• 6.6 Ache Laboratorios Farmaceuticos
• 6.7 Almirall
• 6.8 Aquinox Pharmaceuticals
• 6.9 Ario Pharma
• 6.10 Asmacure
• 6.11 Astellas Pharma
• 6.12 BioMarck Pharmaceuticals
• 6.13 0

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion

Summary

Market Segment as follows:
By Type
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
By Application
GOLD 1? FEV1 ? 80%
GOLD 2? 50% ? FEV1 < 80%
GOLD 3? 30% ? FEV1 < 50%
GOLD 4? FEV1 < 30%
By Company
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
0
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.